Effect of AZD4017, a Selective 11ß-HSD1 Inhibitor, on Bone Turnover Markers in Postmenopausal Osteopenia. (2022)
Attributed to:
Centre for Integrated research into Musculoskeletal Ageing (CIMA) Renewal
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1210/clinem/dgac100
PubMed Identifier: 35275196
Publication URI: http://europepmc.org/abstract/MED/35275196
Type: Journal Article/Review
Volume: 107
Parent Publication: The Journal of clinical endocrinology and metabolism
Issue: 7
ISSN: 0021-972X